The Role of TNF-\(\alpha\) in Mice with Type 1- and 2- Diabetes

DSpace/Manakin Repository

The Role of TNF-\(\alpha\) in Mice with Type 1- and 2- Diabetes

Citable link to this page

 

 
Title: The Role of TNF-\(\alpha\) in Mice with Type 1- and 2- Diabetes
Author: Bhasin, Manoj; Awdeh, Zuheir; Qipo, Andi; Putheti, Prabhakar; Shi, Hang; Csizuadia, Eva; Koulmanda, Maria; Fan, Zhigang; Hanidziar, Dusan; Libermann, Towia Aron; Strom, Terry Barton

Note: Order does not necessarily reflect citation order of authors.

Citation: Koulmanda, Maria, Manoj Bhasin, Zuheir Awdeh, Andi Qipo, Zhigang Fan, Dusan Hanidziar, Prabhakar Putheti, et al. 2012. The role of TNF-\(\alpha\) in mice with type 1- and 2- diabetes. PLoS ONE 7(5): e33254.
Full Text & Related Files:
Abstract: Background: Previously, we have demonstrated that short-term treatment of new onset diabetic Non-obese diabetic (NOD) mice, mice that are afflicted with both type 1 (T1D) and type 2 (T2D) diabetes with either Power Mix (PM) regimen or alpha1 antitrypsin (AAT) permanently restores euglycemia, immune tolerance to self-islets and normal insulin signaling. Methodology and Principal Findings: To search for relevant therapeutic targets, we have applied genome wide transcriptional profiling and systems biology oriented bioinformatics analysis to examine the impact of the PM and AAT regimens upon pancreatic lymph node (PLN) and fat, a crucial tissue for insulin dependent glucose disposal, in new onset diabetic non-obese diabetic (NOD) mice. Systems biology analysis identified tumor necrosis factor alpha (TNF-\(\alpha\)) as the top focus gene hub, as determined by the highest degree of connectivity, in both tissues. In PLNs and fat, TNF-\(\alpha\) interacted with 53% and 32% of genes, respectively, associated with reversal of diabetes by previous treatments and was thereby selected as a therapeutic target. Short-term anti-TNF-\(\alpha\) treatment ablated a T cell-rich islet-invasive and beta cell-destructive process, thereby enhancing beta cell viability. Indeed anti-TNF-\(\alpha\) treatment induces immune tolerance selective to syngeneic beta cells. In addition to these curative effects on T1D anti-TNF-e33254 treatment restored in vivo insulin signaling resulting in restoration of insulin sensitivity. Conclusions: In short, our molecular analysis suggested that PM and AAT both may act in part by quenching a detrimental TNF-\(\alpha\) dependent effect in both fat and PLNs. Indeed, short-term anti-TNF-\(\alpha\) mAb treatment restored enduring euglycemia, self-tolerance, and normal insulin signaling.
Published Version: doi:10.1371/journal.pone.0033254
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350520/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10381374
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters